DrugPatentWatch Database Preview
XOLAIR Drug Profile
Summary for Tradename: XOLAIR
| Patents: | 91 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
Pharmacology for XOLAIR
| Mechanism of Action | IgE-directed Antibody Interactions |
| Physiological Effect | Decreased IgE Activity |
US Patents for XOLAIR
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | XOLAIR | omalizumab | VIAL | 103976 | 001 | 2003-06-20 | ➤ Sign Up | ATOPIX THERAPEUTICS LIMITED (London, GB) | ➤ Sign Up | RX | search | |
| Genentech | XOLAIR | omalizumab | VIAL | 103976 | 001 | 2003-06-20 | ➤ Sign Up | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | ➤ Sign Up | RX | search | |
| Genentech | XOLAIR | omalizumab | VIAL | 103976 | 001 | 2003-06-20 | ➤ Sign Up | Knopp Biosciences LLC (Pittsburgh, PA) | ➤ Sign Up | RX | search | |
| Genentech | XOLAIR | omalizumab | VIAL | 103976 | 001 | 2003-06-20 | ➤ Sign Up | ➤ Sign Up | RX | search | ||
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for XOLAIR
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 5268904 | ➤ Sign Up |
| Canada | 2814040 | ➤ Sign Up |
| European Patent Office | 1943204 | ➤ Sign Up |
| Denmark | 2154223 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for XOLAIR
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 93138 | Luxembourg | ➤ Sign Up | PRODUCT NAME: RITUXIMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20140326 |
| 92780 | Luxembourg | ➤ Sign Up | PRODUCT NAME: TRASTUZUMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20130826 |
| CA 2016 00031 | Denmark | ➤ Sign Up | PRODUCT NAME: RITUXIMAB AND RECOMBINANT HUMAN HYALURONIDASE; REG. NO/DATE: EU/1/98/067 20140326 |
| PA2015031 | Lithuania | ➤ Sign Up | PRODUCT NAME: TRASTUZUMABAS IR REKOMBINANTINE ZMOGAUS HIALURONIDAZE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
